Effects of ciclesonide on lung function and cortisol excretion in adolescent asthma patients – a comparative study with budesonide Source: Eur Respir J 2006; 28: Suppl. 50, 206s Year: 2006
Effect of administration of intranasal fluticasone propionate on lower leg growth rate in children with rhinitis Source: Eur Respir J 2001; 18: Suppl. 33, 290s Year: 2001
Efficacy and safety of ciclesonide compared with fluticasone propionate or budesonide in adolescent patients with persistent asthma Source: Eur Respir J 2007; 30: Suppl. 51, 458s Year: 2007
Efficacy of salmeterol/fluticasone propionate MDI versus higher dose fluticasone propionate in adolescent and adult asthmatics uncontrolled on fluticasone propionate alone Source: Eur Respir J 2003; 22: Suppl. 45, 438s Year: 2003
Efficacy and safety of ciclesonide compared with fluticasone propionate in patients with moderate to severe asthma Source: Eur Respir J 2006; 28: Suppl. 50, 206s Year: 2006
Safety profile of ciclesonide as compared with fluticasone propionate in the treatment of children and adolescents with asthma Source: Eur Respir J 2004; 24: Suppl. 48, 346s Year: 2004
Effect of inhaled corticosteroid fluticasone propionate on linear growth in preschool children with asthma Source: Annual Congress 2007 - Anti-inflammatory therapy for childhood asthma Year: 2007
Ciclesonide and fluticasone propionate show comparable efficacy in children and adolescents with asthma Source: Eur Respir J 2004; 24: Suppl. 48, 346s Year: 2004
Comparable efficacy of ciclesonide and fluticasone propionate and lower incidence of oropharyngeal candidiasis with ciclesonide in patients with well-controlled moderate to severe persistent asthma Source: Eur Respir J 2007; 30: Suppl. 51, 351s Year: 2007
The effects of fluticasone propionate in asthmatic patients Source: Eur Respir J 2004; 24: Suppl. 48, 125s Year: 2004
Comparison of once-daily ciclesonide 160 μg versus twice-daily fluticasone propionate 88 μg in children with moderate to severe asthma Source: Eur Respir J 2006; 28: Suppl. 50, 711s Year: 2006
Equivalent bone safety and better efficacy of fluticasone propionate compared to nedocromil sodium in asthmatic children. Results of a 2-year randomized study Source: Eur Respir J 2002; 20: Suppl. 38, 219s Year: 2002
Growth in asthmatic children treated with fluticasone propionate Source: Eur Respir J 2002; 20: Suppl. 38, 218s Year: 2002
Effect of addition of salmeterol vs doubling the dose of fluticasone propionate on specific airway resistance in children with asthma Source: Annual Congress 2008 - Drug therapy and assessment of control in childhood asthma Year: 2008
Comparative study of 8-weeks treatment of asthma exacerbations in adults with high doses of budesonide versus fluticasone Source: Eur Respir J 2001; 18: Suppl. 33, 97s Year: 2001
Urine cortisol excretion in children 4–11 years old is not affected by therapeutic doses of fluticasone propionate HFA Source: Eur Respir J 2006; 28: Suppl. 50, 260s Year: 2006
Fluticasone propionate in asthmatic children: a long term dose comparison of safety and efficacy Source: Eur Respir J 2001; 18: Suppl. 33, 288s Year: 2001
The results of using the high doses of fluticasone propionate in childhood asthma Source: Eur Respir J 2002; 20: Suppl. 38, 432s Year: 2002
Efficacy of high-dose inhaled fluticasone propionate in Indian patients having moderate asthma Source: Eur Respir J 2002; 20: Suppl. 38, 305s Year: 2002
Effects on adrenal function of a new combination of fluticasone propionate/formoterol fumarate administered to asthmatic patients and healthy subjects Source: Annual Congress 2011 - Airways disease comorbidities and general aspects Year: 2011